Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease (IBD) have been dashed. | Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease ...

Conformal Medical has raised $32 million to support the development of its heart implant designed to reduce the lifetime risk ...

Hatteras Venture Partners has secured over $200 million across a pair of funds that are set to benefit up-and-coming biotechs ...

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

Oric Pharmaceuticals’ previously announced plan to focus resources on its two most advanced oncology drugs comes with a sting ...

Generation Bio is shedding 90% of its workforce after the biotech acknowledged that it’s unlikely to find the cash to take ...